AbbVie Puts Final Nail In Rova-T's Coffin After Another Trial Failure

 
• By Mandy Jackson
Rusty-nail
Rova-T was all but dead until the ADC's latest failure in SCLC. • Source: Shutterstock

More from Clinical Trials

More from R&D